European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Life Sciences & Pharma

Unlocking Growth: Singapore's Role in Advancing Life Sciences and Medtech Innovations

March 10, 2025

Executive Insights

Digital

Your AI Transformation Needs a Different Leadership Approach

March 7, 2025

Executive Insights

Life Sciences & Pharma

From Niche to Widespread Use: The Turning Point for Radiotherapeutics

November 12, 2024

Executive Insights

Life Sciences & Pharma

Refining Gross-to-Net Expectations for Improved Strategic Planning

November 4, 2024

Executive Insights

Telehealth and Digital Transformation

Healing Bytes: A Prescription for Commercializing Healthcare Data in Asia and the Middle…

October 23, 2024

Published Articles

Consumer Products

Don’t Gamble On Innovation Spending

October 9, 2024